Pfizer, Anumana team up to develop AI algorithm for cardiac amyloidosis detection

Under the multi-year strategic partnership, Anumana will conduct a clinical validation trial and seek FDA De Novo classification for the algorithm.
Source: mobihealthnews - Category: Information Technology Source Type: news